Novartis Pharmaceuticals Corporation secures contract for Supply Of Lutathera(r) (Lutetium Lu 177 Dotatate) And Pluvicto(tm) (Lutetium Lu 177 Vipivotide Tetraxetan)

Posted On: 2026-10-09

United States, Oct. 9 -- United States based Novartis Pharmaceuticals Corporation has secured contract from Dept Of Defense for Supply Of Lutathera(r) (Lutetium Lu 177 Dotatate) And Pluvicto(tm) (Lutetium Lu 177 Vipivotide Tetraxetan). The value of the contract is 480119.64 USD.

Published by HT Digital Content Services with permission from Pivotal Sources....

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Novartis Pharmaceuticals Corporation secures contract for Supply Of Lutathera(r) (Lutetium Lu 177 Dotatate) And Pluvicto(tm) (Lutetium Lu 177 Vipivotide Tetraxetan)